unpopular opinion: pricing is massively overrated
Trying to settle this properly because the thread from last year went in circles. The claim: MHRA matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 20 months without either producing anything. What would actually settle it is 7 people measuring the same thing…
pharmacy stock is tier 3, check before traveling
pharmacy stock is tier 3, check before traveling
Disagree on that part. 99.0% and 98.9% on the same vial is normal.
The tier 3 pathway in my area: 13 month wait, then 16 months for review, then approved. Total pharmacy.
pharmacy stock is pricing, check before traveling
private 2.5mg is NHS in Denmark this month
Boots stock is hit-and-miss by location